OWL-1023-AI

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameOWL-1023-AI
Drug Alias NameOWL-1023-AI
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAlzheimer DiseaseBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOwl Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesOwl Therapeutics
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseBrain Injuries, Traumatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A